Skip to main content

Clinical Trials Using HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202

Review the clinical trials studying hpv 16 e6/e7-encoding arenavirus vaccine hb-202 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-2 of 2

A Vaccine (HB-200) for the Treatment of HPV16 Positive Head and Neck Squamous Cell Cancer with Positive TTMV-HPV DNA after Definitive Treatment
Status: Active
Location: 7 locations
Vaccines (TheraT Vectors) with Carboplatin and Paclitaxel prior to Transoral Robotic Surgery, Radiation Therapy, or Chemoradiation for the Treatment of HPV16 Positive Oropharyngeal Cancer, The TARGET HPV Study
Status: Temporarily Closed to Accrual
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois